Author: VJNeurology

Anne Schlag, PhD, Drug Science, London, UK, shares real-world registry data from patients using cannabis-based medical products for chronic pain, after 3-months of use. The registry, Project T21, aims to advance scientific evidence on medical cannabis and has enrolled over 3,500 patients using cannabis-based medical products for a range of conditions. Chronic pain was the most commonly reported reason for medical cannabis use and initial baseline data revealed low general health scores among these participants. However, 3-month data from 618 patients demonstrated significant improvements across general health, quality of life, mood, and sleep quality. Notably, both pain intensity and pain…

Anne Schlag, PhD, Drug Science, UK, discusses the mission of the UK charity, Drug Science, which aims to collect scientific evidence relating to psychoactive drugs to support effective drug laws and policy changes. The charity’s Medical Cannabis Working Group addresses issues that still persist four years after the legalization of medical cannabis in the UK, particularly the lack of NHS prescriptions for medical cannabis products. They hope to broaden the range of patients and conditions considered for medical cannabis prescriptions, beyond the limited four conditions currently recommended by NICE. Dr Schlag highlights how pain relief is excluded, despite it being…